RSV-F vaccine: Completed Phase I enrollment

Novavax completed enrollment of about 150 healthy volunteers ages 18-49 in a double-blind,

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE